111 web-programmer-developer-"https:" "https:" "https:" "https:" positions at City of Hope
Sort by
Refine Your Search
-
epidemiological methodologies to advance our understanding of the germline genetic risk, somatic drivers, and early-life origins of childhood leukemia, with the goal of developing strategies for disease prevention
-
I position is available in the RSP Lab led by Dr. Sklavenitis Pistofidis. The RSP Lab (https://rsplab.org ) leverages advanced multi-omic technologies, coupled with experimental perturbations and
-
, shaping the future of medicine through cutting-edge research. A Postdoctoral Fellowship position is available in the RSP Lab led by Dr. Sklavenitis Pistofidis. The RSP Lab (https://rsplab.org ) leverages
-
bone marrow transplantation. We are looking for a highly motivated candidate with a PhD degree interested in using microbiological methods with the aim of developing novel strategies to improve bone
-
position is available in the RSP Lab led by Dr. Sklavenitis Pistofidis. The RSP Lab (https://rsplab.org ) leverages advanced multi-omic technologies, coupled with experimental perturbations and
-
Fellowship position is available in the RSP Lab led by Dr. Sklavenitis Pistofidis. The RSP Lab (https://rsplab.org ) leverages advanced multi-omic technologies, coupled with experimental perturbations and
-
to immunotherapies for type 1 diabetes as well as somatic variants in the pancreas and immune cells of organ donors with type 1 diabetes. For more information on the Shapiro Laboratory please visit here: https
-
and validate experimental plan, methods, and results for accuracy and completeness. Develop new laboratory methods and help refine existing methodologies. Your qualifications should include
-
models to study metabolic diseases is preferred. For a complete list of Publications please visit here: https://www.ncbi.nlm.nih.gov/myncbi/1J54E41I5YVku/bibliography/public/ Your qualifications should
-
genes related to the development of type 2 diabetes and cardiovascular disease in the Hispanic population. He also continues to oversee the Diabetes and Cardiovascular Risk Reduction Program, which he